Hospital
Straub Clinic & Hospital
Straub Clinic & Hospital was paid $45.59M by Medicaid between Jan 2018 and Dec 2024, across 328 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoSTRAUB CLINIC & HOSPITAL
HONOLULU, HI 96813
HONOLULU, HI 96813
33aNPI1720031701assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$45.59M
24GClaims912,398
24DCodes billed328
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Hawaii
Rank by total paid#5 of 18
Median peer was paid$10.94M
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 146,507 | $6.63M | |
| 2019 | 154,582 | $6.69M | |
| 2020 | 106,030 | $4.57M | |
| 2021 | 131,989 | $6.07M | |
| 2022 | 137,300 | $6.60M | |
| 2023 | 132,889 | $7.18M | |
| 2024incomplete | 103,101 | $7.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 13,718 | 12,073 | $10.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 19,410 | 17,095 | $9.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 13,431 | 12,177 | $7.76M |
| G0378 | Hospital observation service, per hour | 7.7% | 3,080 | 2,596 | $3.51M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 6,485 | 5,877 | $2.39M |
| L8699 | Prosthetic implant, not otherwise specified | 4.8% | 1,224 | 1,099 | $2.21M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 3,016 | 2,842 | $1.68M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 1,855 | 1,756 | $768K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 21,597 | 8,814 | $677K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.5% | 2,177 | 1,946 | $665K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.4% | 1,617 | 1,532 | $650K |
| 80061 | Lipid panel | <1% | 15,274 | 14,696 | $380K |
316 more codes
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 14,204 | $328K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,532 | $327K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 50,530 | $281K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,319 | $280K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,566 | $221K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,013 | $215K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,369 | $201K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 375 | $172K |
| J0897 | Injection, denosumab, 1 mg | <1% | 237 | $144K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,623 | $144K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 25,121 | $140K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 243 | $140K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,575 | $136K |
| A4649 | Surgical supply; miscellaneous | <1% | 47,618 | $130K |
| 97161 | <1% | 3,424 | $124K | |
| 80053 | Comprehensive metabolic panel | <1% | 40,711 | $110K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,216 | $101K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 7,478 | $100K |
| 87186 | <1% | 4,417 | $82K | |
| 71250 | <1% | 656 | $70K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,101 | $67K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,228 | $60K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 836 | $54K |
| 76770 | <1% | 1,036 | $52K | |
| 97165 | <1% | 1,790 | $50K | |
| 73522 | <1% | 772 | $46K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,897 | $45K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,227 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,437 | $40K |
| 84153 | <1% | 1,664 | $40K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,611 | $40K |
| 86235 | <1% | 675 | $40K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 575 | $39K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,509 | $38K |
| 73030 | <1% | 2,356 | $36K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,305 | $34K |
| 83516 | <1% | 580 | $33K | |
| 83655 | <1% | 1,886 | $30K | |
| 76536 | <1% | 613 | $30K | |
| 73562 | <1% | 2,217 | $30K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 780 | $30K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,109 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 49,210 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15,097 | $24K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 67 | $24K |
| 73564 | <1% | 1,145 | $24K | |
| 93017 | <1% | 677 | $24K | |
| G0423 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | <1% | 89 | $23K |
| 73630 | <1% | 1,704 | $22K | |
| 83880 | <1% | 4,097 | $21K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 159 | $21K |
| 73130 | <1% | 1,345 | $20K | |
| 96367 | <1% | 2,218 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 14,563 | $19K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 331 | $19K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 6,303 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,615 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,949 | $17K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 41 | $17K |
| 86003 | <1% | 204 | $16K | |
| 80055 | <1% | 92 | $16K | |
| 82607 | <1% | 2,269 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,855 | $15K |
| 73610 | <1% | 1,140 | $14K | |
| 90662 | <1% | 485 | $13K | |
| 72100 | <1% | 735 | $13K | |
| 92083 | <1% | 366 | $13K | |
| 93971 | <1% | 245 | $13K | |
| 86160 | <1% | 337 | $12K | |
| 36591 | <1% | 1,117 | $12K | |
| 82728 | <1% | 1,398 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 8,331 | $11K |
| 92134 | <1% | 966 | $10K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 365 | $10K |
| 94010 | <1% | 305 | $9K | |
| 81513 | <1% | 27 | $9K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 426 | $9K |
| 86803 | <1% | 457 | $8K | |
| 87081 | <1% | 1,546 | $8K | |
| 74018 | <1% | 446 | $8K | |
| 72110 | <1% | 198 | $8K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 828 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 827 | $7K |
| 87070 | <1% | 3,061 | $7K | |
| 86480 | <1% | 42 | $7K | |
| 87077 | <1% | 6,376 | $7K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 613 | $6K |
| 76642 | <1% | 237 | $6K | |
| 73110 | <1% | 493 | $6K | |
| 85027 | <1% | 1,284 | $6K | |
| 97162 | <1% | 116 | $6K | |
| 86850 | <1% | 1,822 | $6K | |
| A4300 | Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access | <1% | 14,403 | $5K |
| 36430 | <1% | 81 | $5K | |
| 73502 | <1% | 260 | $5K | |
| 93976 | <1% | 54 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,640 | $5K |
| 88341 | <1% | 65 | $4K | |
| 81001 | <1% | 15,683 | $4K | |
| 85379 | <1% | 2,078 | $4K | |
| 88112 | <1% | 128 | $4K | |
| 85610 | <1% | 11,832 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 253 | $4K |
| 77080 | <1% | 73 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,883 | $3K |
| 87075 | <1% | 1,069 | $3K | |
| 88304 | <1% | 170 | $3K | |
| 73560 | <1% | 224 | $3K | |
| 86334 | <1% | 130 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,203 | $3K |
| 84703 | <1% | 615 | $3K | |
| 80076 | <1% | 2,085 | $3K | |
| 94060 | <1% | 74 | $3K | |
| 84702 | <1% | 265 | $3K | |
| A9270 | Non-covered item or service | <1% | 5,908 | $3K |
| 84403 | <1% | 53 | $3K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $3K |
| 86038 | <1% | 1,062 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 90 | $2K |
| 82043 | <1% | 3,637 | $2K | |
| 93990 | <1% | 49 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,709 | $2K |
| 97116 | <1% | 1,059 | $2K | |
| 71101 | <1% | 241 | $2K | |
| 83550 | <1% | 1,577 | $2K | |
| 87040 | <1% | 4,368 | $2K | |
| Q3014 | Telehealth originating site facility fee | <1% | 723 | $2K |
| 87480 | <1% | 74 | $2K | |
| 70486 | <1% | 58 | $2K | |
| J3490 | Unclassified drugs | <1% | 29,649 | $2K |
| 82378 | <1% | 99 | $2K | |
| 84484 | <1% | 8,902 | $1K | |
| 94729 | <1% | 274 | $1K | |
| 87899 | <1% | 149 | $1K | |
| 86920 | <1% | 92 | $1K | |
| 94726 | <1% | 28 | $1K | |
| 74022 | <1% | 275 | $1K | |
| 73140 | <1% | 105 | $969.47 | |
| 86140 | <1% | 4,277 | $934.27 | |
| 72050 | <1% | 25 | $890.19 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,303 | $868.80 |
| 92133 | <1% | 242 | $862.15 | |
| 84439 | <1% | 3,212 | $860.35 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 260 | $767.87 |
| 90715 | <1% | 1,260 | $752.32 | |
| A4550 | Surgical trays | <1% | 2,561 | $726.66 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 129 | $704.46 |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $702.38 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 367 | $700.56 |
| 83690 | <1% | 7,178 | $687.91 | |
| 86225 | <1% | 415 | $676.23 | |
| 82565 | <1% | 1,787 | $605.81 | |
| 83605 | <1% | 5,929 | $585.22 | |
| 86255 | <1% | 39 | $553.04 | |
| 85730 | <1% | 2,613 | $515.78 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 916 | $497.23 |
| 82570 | <1% | 4,214 | $484.59 | |
| 83735 | <1% | 6,271 | $482.76 | |
| 82784 | <1% | 400 | $468.51 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,473 | $457.96 |
| 0450 | Emergency room services | <1% | 12 | $431.38 |
| 85014 | <1% | 1,876 | $430.52 | |
| 72040 | <1% | 26 | $427.65 | |
| 84165 | <1% | 396 | $424.85 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,605 | $411.50 |
| 81025 | <1% | 3,157 | $410.41 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,799 | $400.73 |
| 84550 | <1% | 2,041 | $379.20 | |
| 83001 | <1% | 12 | $359.56 | |
| 82533 | <1% | 65 | $333.27 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 58,056 | $327.53 |
| 85018 | <1% | 2,351 | $313.67 | |
| 82550 | <1% | 2,385 | $302.16 | |
| 73080 | <1% | 13 | $294.24 | |
| 82746 | <1% | 301 | $293.15 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,250 | $292.79 |
| 86200 | <1% | 120 | $282.40 | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 119 | $269.35 |
| 86592 | <1% | 911 | $257.84 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 27 | $255.74 |
| 96376 | <1% | 4,188 | $231.12 | |
| 81003 | <1% | 1,421 | $230.89 | |
| 36592 | <1% | 275 | $216.41 | |
| 82950 | <1% | 82 | $212.99 | |
| 84460 | <1% | 1,054 | $186.54 | |
| 82803 | <1% | 814 | $185.47 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,335 | $183.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,242 | $162.26 |
| J1815 | Injection, insulin, per 5 units | <1% | 764 | $157.38 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,123 | $149.04 |
| 88342 | <1% | 629 | $144.78 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,790 | $143.89 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 88 | $139.05 |
| 84132 | <1% | 424 | $129.51 | |
| 20610 | <1% | 38 | $114.40 | |
| 86706 | <1% | 58 | $110.74 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,855 | $106.00 |
| 80069 | <1% | 43 | $89.31 | |
| 85651 | <1% | 4,552 | $80.90 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 975 | $78.02 |
| 86901 | <1% | 2,004 | $73.61 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,351 | $73.07 |
| 73600 | <1% | 15 | $70.28 | |
| 80051 | <1% | 209 | $69.81 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 192 | $68.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,691 | $64.92 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 7,044 | $64.32 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 879 | $58.85 |
| 87184 | <1% | 2,475 | $54.15 | |
| 87088 | <1% | 244 | $50.18 | |
| 83615 | <1% | 573 | $44.15 | |
| 82947 | <1% | 909 | $43.03 | |
| 82785 | <1% | 39 | $42.88 | |
| J2704 | Injection, propofol, 10 mg | <1% | 7,283 | $42.81 |
| A4217 | Sterile water/saline, 500 ml | <1% | 1,045 | $39.86 |
| G0008 | Administration of influenza virus vaccine | <1% | 1,349 | $31.77 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 77 | $29.90 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 547 | $29.58 |
| 83540 | <1% | 1,649 | $29.38 | |
| 84100 | <1% | 1,651 | $26.82 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 830 | $26.54 |
| 69210 | <1% | 38 | $25.92 | |
| 94761 | <1% | 12 | $25.27 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 296 | $24.74 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,565 | $22.63 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,011 | $22.17 |
| 80305 | <1% | 27 | $21.11 | |
| 87340 | <1% | 88 | $17.98 | |
| 94644 | <1% | 208 | $17.00 | |
| 36416 | <1% | 1,771 | $14.75 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 486 | $14.11 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 425 | $13.86 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 15 | $13.41 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 212 | $12.96 |
| 86900 | <1% | 1,994 | $12.30 | |
| 92567 | <1% | 52 | $11.70 | |
| 97035 | <1% | 201 | $10.42 | |
| 84295 | <1% | 61 | $9.65 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 15 | $9.61 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 750 | $9.18 |
| 84156 | <1% | 168 | $6.39 | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 397 | $6.00 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 311 | $4.20 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 35 | $3.15 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 527 | $3.12 |
| A4620 | Variable concentration mask | <1% | 1,780 | $1.88 |
| A4215 | Needle, sterile, any size, each | <1% | 2,760 | $1.65 |
| A6446 | Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard | <1% | 47 | $1.64 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 1,376 | $1.01 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,178 | $0.50 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 2,656 | $0.00 |
| A7521 | Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each | 0% | 408 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 827 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,873 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 15 | $0.00 |
| 90686 | 0% | 936 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 13 | $0.00 |
| A4467 | Belt, strap, sleeve, garment, or covering, any type | 0% | 1,362 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 1,028 | $0.00 |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | 0% | 1,641 | $0.00 |
| 51798 | 0% | 319 | $0.00 | |
| C1769 | Guide wire | 0% | 31 | $0.00 |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | 0% | 268 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 152 | $0.00 |
| 80320 | 0% | 70 | $0.00 | |
| 96415 | 0% | 226 | $0.00 | |
| 87205 | 0% | 256 | $0.00 | |
| 88738 | 0% | 32 | $0.00 | |
| A4616 | Tubing (oxygen), per foot | 0% | 73 | $0.00 |
| 87046 | 0% | 63 | $0.00 | |
| A4209 | Syringe with needle, sterile 5 cc or greater, each | 0% | 117 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 54 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 203 | $0.00 |
| 90656 | 0% | 57 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 37 | $0.00 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 0% | 14 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 41 | $0.00 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | 0% | 21 | $0.00 |
| 87015 | 0% | 58 | $0.00 | |
| 87510 | 0% | 74 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 16 | $0.00 |
| 84160 | 0% | 12 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 13 | $0.00 |
| 77001 | 0% | 13 | $0.00 | |
| A4618 | Breathing circuits | 0% | 1,552 | $0.00 |
| 86431 | 0% | 751 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 920 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 14 | $0.00 |
| 84450 | 0% | 859 | $0.00 | |
| 87660 | 0% | 74 | $0.00 | |
| 84520 | 0% | 311 | $0.00 | |
| 10060 | 0% | 39 | $0.00 | |
| 82948 | 0% | 96 | $0.00 | |
| 87045 | 0% | 63 | $0.00 | |
| 84145 | 0% | 18 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 65 | $0.00 |
| 89051 | 0% | 28 | $0.00 | |
| 86039 | 0% | 42 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 98 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 48 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 112 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 299 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 38 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 138 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 54 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 14 | $0.00 |
| 82310 | 0% | 12 | $0.00 | |
| A6258 | Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 0% | 80 | $0.00 |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 0% | 13 | $0.00 |
| 87481 | 0% | 42 | $0.00 | |
| 92557 | 0% | 13 | $0.00 | |
| 82010 | 0% | 40 | $0.00 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 57 | $0.00 |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 0% | 90 | $0.00 |
| 84425 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOKABE, DAVID (CFO)
| Provider | Location | Paid |
|---|---|---|
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $102.45M |
| Pali Momi Medical Center | Aiea, HI | $49.28M |
| Straub Clinic & Hospital | Honolulu, HI | $8.19M |
| Kapiolani Medical Specialists | Honolulu, HI | $5.15M |
| Kauai Medical Clinic | Lihue, HI | $4.98M |
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $3.29M |
| Straub Clinic & Hospital | Honolulu, HI | $985K |
| Pali Momi Medical Center | Aiea, HI | $598K |
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $154K |
| Straub Clinic & Hospital | Honolulu, HI | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.